Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
The purpose of this study was to examine the toxicity of combining oncolytic adenovirus-mediated cytotoxic and interleukin 12 (IL-12) gene therapy in a preclinical model to support future phase 1 trials. One hundred and twenty C57BL/6 male mice received an intraprostatic injection of saline (n = 24)...
Main Authors: | Svend O Freytag, Yingshu Zhang, Farzan Siddiqui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770516300080 |
Similar Items
-
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer
by: Kenneth N. Barton, et al.
Published: (2021-03-01) -
Oncolytic adenovirus-mediated therapy for prostate cancer
by: Sweeney K, et al.
Published: (2016-07-01) -
Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation
by: Li-jun Mao, et al.
Published: (2020-04-01) -
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
by: Kiyokawa J, et al.
Published: (2019-10-01) -
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01)